Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

G2 Recognizes SlickText for Outstanding Customer Experience

September 3, 2026

PZZA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Papa John’s (NASDAQ: PZZA) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

September 3, 2026

Modelo® Raises a Glass to the Fans Keeping College Football Traditions Alive in New “It’s Not Just Game Day. It’s Tradition.” Campaign

September 3, 2026

Phemex Reinforces Institutional Safety with 100%+ September Reserves

September 3, 2026

Praytell Expands “Centers of Influence” Department to Guide Brands Through “The Personality Era,” Adding Powerhouse Talent

September 3, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Bonafide® Health Launches Noctera™ – A Novel, Hormone-Free Supplement Designed to Improve Sleep Quality and Duration Negatively Impacted by Hormonal Changes
Press Release

Bonafide® Health Launches Noctera™ – A Novel, Hormone-Free Supplement Designed to Improve Sleep Quality and Duration Negatively Impacted by Hormonal Changes

By News RoomFebruary 19, 20264 Mins Read
Bonafide® Health Launches Noctera™  – A Novel, Hormone-Free Supplement Designed to Improve Sleep Quality and Duration Negatively Impacted by Hormonal Changes
Share
Facebook Twitter LinkedIn Pinterest Email

New York, NY, Feb. 19, 2026 (GLOBE NEWSWIRE) — Bonafide Health, LLC, a women’s healthcare company dedicated to providing science-backed solutions for perimenopause and menopause symptoms, has launched Noctera™, a hormone-free, prescription-free supplement designed to improve sleep quality and duration in women impacted by hormonal changes. Noctera™ is available online at Bonafide’s website and on Amazon.

Sleep disturbances are among the most common challenges faced by women aged 40 to 64, which can be linked to the hormonal fluctuations experienced during the menopause transition. Many report trouble getting to sleep initially, staying asleep, and possibly the most disruptive, falling back to sleep after waking during the night. Noctera’s unique continuous release formula is designed to help balance the body’s natural sleep signals, calming the ‘busy mind’, to improve sleep quality, reduce sleep disturbances and ultimately improve daytime energy.

Noctera works through GABAergic and Glutamate pathways, addressing sleep disruptions by rebalancing the inhibitory (calming) and excitatory pathways in the brain. Noctera is a drug-free dietary supplement. Its formula is non-sedative and is designed to support sleep without next-day grogginess, while remaining safe for daily use.

Noctera’s four key ingredients are specially formulated for maximum effectiveness:

  • Magnesium Glycinate: Blocks the excitatory signal causing wakefulness
  • GABA: Promotes relaxation and calms the mind, for better sleep
  • L-theanine: Works with the magnesium to block the excitatory signals in the brain and rebalance the sleep-wake cycle
  • SAMe: Further promotes sleep regulation and rebalance

Clinically studied in women experiencing hormonal changes due to menopause, Noctera targets the root cause of menopausal sleep disruptions. A randomized, double-blind, placebo-controlled trial demonstrated that Noctera significantly enhances sleep quality in perimenopausal and postmenopausal women who are experiencing moderate-to-severe sleep disturbances. The supplement demonstrated a favorable safety profile throughout the study, with no significant adverse effects reported. *

Key findings from this study include:1

  • 88% of women experiencing moderate-to-severe sleep issues experienced reduced sleep disturbances, moving to ‘within normal limits’ within 3 weeks of using Noctera
  • Women experienced an average increase in sleep duration of 40 minutes
  • 89% of women found it easier to fall back asleep after waking in the night when taking Noctera consistently as directed
  • Women also subsequently reported improvement in morning grogginess, ease of getting out of bed, restfulness, daytime sleepiness and sleep satisfaction

“Estrogen plays a critical role in how our brain regulates temperature, sleep, and mood,” explains Dr. Alyssa Dweck, MS MD FACOG, MSCP, Bonafide’s Chief Medical Officer and co-author of the Noctera studies. “Declining estrogen levels during the menopause transition affect the balance of both GABA, a calming neurotransmitter in the brain and Glutamate, an excitatory one. This imbalance has direct effects on sleep, specifically associated with the frequent nocturnal awakenings and difficulty falling back asleep during this time of life.”

Bonafide partners with FDA-registered, GMP (good manufacturing practice certified) manufacturing facilities and rigorously tests each of their products for consistency, quality, purity, and potency. Noctera is available for purchase without a prescription on Bonafide’s website www.hellobonafide.com – where monthly subscriptions are $33.99/m, and 3-month subscriptions are $29.99/m.

ABOUT BONAFIDE HEALTH, LLC

Bonafide Health was launched with a simple mission: to provide women with safe and highly effective symptom relief throughout their menopause journey. As part of Bonafide’s scientific research and product development process, the brand prides itself on their deep understanding of the biological and physiological changes that affect women due to hormonal fluctuations experienced with age. Trusted by more than 13K doctors, Bonafide provides first-of-its-kind, evidence-based solutions developed from naturally derived ingredients that are hormone-free and drug-free. To learn more visit www.hellobonafide.com

 Resources

*Sleep disturbances measured in clinical studies with perimenopausal and menopausal women using T-scores on the PROMIS-SD, a validated clinical questionnaire.

  1. Effect of a Nonhormonal Sleep Supplement on Sleep Quality in Peri- and Postmenopausal Females: A Randomized, Double-Blind, Placebo-Controlled Trial. Stephen Carbonneau, Alyssa Dweck, Trisha VanDusseldorp, Vincent Mysliwiec, Matthew Stratton, Michaela Alesi, Laura Mason, Will Mykytiuk, James Komorowski Sleep, Volume 48, Issue Supplement_1, May 2025, Pages A402–A403, https://doi.org/10.1093/sleep/zsaf090.0927
  • Bonafide® Health Launches Noctera™
  • Bonafide® Health Launches Noctera™
            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

G2 Recognizes SlickText for Outstanding Customer Experience

PZZA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Papa John’s (NASDAQ: PZZA) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Modelo® Raises a Glass to the Fans Keeping College Football Traditions Alive in New “It’s Not Just Game Day. It’s Tradition.” Campaign

Phemex Reinforces Institutional Safety with 100%+ September Reserves

Praytell Expands “Centers of Influence” Department to Guide Brands Through “The Personality Era,” Adding Powerhouse Talent

Philips advances women’s health ultrasound with new single-transducer solution

Anonymous Alerts Opens New Stamford Headquarters to Fuel School Safety Expansion

High-Brightness Light-Emitting Diodes (LED) Headlamps Market Outlook 2026-2030 Featuring Profiles of Koito Manufacturing, Valeo and Stanley Electric

Kochava Unveils Creative Services Workspaces on StationOne, Featuring Leading Partners Higgsfield, Luma, and Spaceback by Rembrand

Editors Picks

PZZA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Papa John’s (NASDAQ: PZZA) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

September 3, 2026

Modelo® Raises a Glass to the Fans Keeping College Football Traditions Alive in New “It’s Not Just Game Day. It’s Tradition.” Campaign

September 3, 2026

Phemex Reinforces Institutional Safety with 100%+ September Reserves

September 3, 2026

Praytell Expands “Centers of Influence” Department to Guide Brands Through “The Personality Era,” Adding Powerhouse Talent

September 3, 2026

Latest News

Philips advances women’s health ultrasound with new single-transducer solution

September 3, 2026

Anonymous Alerts Opens New Stamford Headquarters to Fuel School Safety Expansion

September 3, 2026

N.S. woman says her family has lost hundreds of relatives, friends in Nepal floods

September 3, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version